SAMVIG

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameSAMVIG
Drug Alias NameSelf-amplifying mRNA VLV system
ClassificationCell and gene therapy > Gene therapy > mRNA > self-amplifying mRNA (SAM)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSecond Affiliated Hospital Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesSecond Affiliated Hospital Of Zhejiang University School Of Medicine
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A